Biochemical and cytological features of metastatic pleural effusions in breast cancer

M. Medenica (Niksic, Serbia And Montenegro)

Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Session: Prognosis and diagnosis of thoracic malignancies
Session type: Thematic Poster Session
Number: 3905
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Medenica (Niksic, Serbia And Montenegro). Biochemical and cytological features of metastatic pleural effusions in breast cancer. Eur Respir J 2007; 30: Suppl. 51, 3905

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma
Source: Eur Respir J 2005; 26: Suppl. 49, 74s
Year: 2005

Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006

Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007


Pleural effusion in cases of breast carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 62s
Year: 2003

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Epidemiology and clinical problems of orphant pleural adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Pleural effusions in lung cancer
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012

An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Lung cancer and pleural mesothelioma
Source: Eur Respir Monogr 2014; 65: 48-60
Year: 2014


Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009


Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Ultra-late pleural metastasis of breast cancer: are they so rare?
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020